Showing results (1-10 of 111) with videos related to
Sort By:
Pageof 12
Cancer Chemotherapy and Pharmacology|September 19, 2003
The effect of gefitinib (Iressa, ZD1839) in combination with oxaliplatin is schedule-dependent in colon cancer cell linesJian-Ming Xu, Amalia Azzariti, Giuseppe Colucci, et al.Biochemical Pharmacology|June 9, 2004
The schedule-dependent enhanced cytotoxic activity of 7-ethyl-10-hydroxy-camptothecin (SN-38) in combination with Gefitinib (Iressa, ZD1839)Amalia Azzariti, Jian-Ming Xu, Letizia Porcelli, et al.Cancers|September 11, 2020
The Role of Non-Coding RNAs as Prognostic Factor, Predictor of Drug Response or Resistance and Pharmacological Targets, in the Cutaneous Squamous Cell CarcinomaMarianna Garofoli, Mariateresa Volpicella, Michele Guida, et al.Biochemical Pharmacology|January 15, 2008
Synergic antiproliferative and antiangiogenic effects of EGFR and mTor inhibitors on pancreatic cancer cellsAmalia Azzariti, Letizia Porcelli, Giuliana Gatti, et al.Cancer Chemotherapy and Pharmacology|June 14, 2015
Metastatic melanoma cells with BRAF G469A mutation: nab-paclitaxel better than vemurafenib?Letizia Porcelli, Gabriella Guida, Stefania Tommasi, et al.Current Topics in Medicinal Chemistry|February 10, 2009
Intracellular trafficking of MDR transporters and relevance of SNPsLetizia Porcelli, Clara Lemos, Godefridus J Peters, et al.Current Drug Metabolism|March 26, 2011
The coordinated role of CYP450 enzymes and P-gp in determining cancer resistance to chemotherapyAmalia Azzariti, Letizia Porcelli, Anna Elisa Quatrale, et al.World Journal of Gastroenterology|August 29, 2006
Prolonged exposure of colon cancer cells to the epidermal growth factor receptor inhibitor gefitinib (Iressa(TM)) and to the antiangiogenic agent ZD6474: Cytotoxic and biomolecular effectsAmalia Azzariti, Letizia Porcelli, Jian-Ming Xu, et al.International Journal of Cancer|July 25, 2015
Expression of proteins involved in DNA damage response in familial and sporadic breast cancer patientsGiulia Partipilo, Giovanni Simone, Anna Scattone, et al.Biochemical Pharmacology|December 8, 2005
ZD6474 inhibits proliferation and invasion of human hepatocellular carcinoma cellsGianluigi Giannelli, Amalia Azzariti, Concetta Sgarra, et al.Pageof 12